Management and follow up of prosthetic valve patients

Heart

Volumn 90, Issue 7, 2004, Pages 818-824

  Seiler, Christian ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; FRESH FROZEN PLASMA; VITAMIN K GROUP; WARFARIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; BACTERIAL ENDOCARDITIS; BLEEDING; DRUG INDICATION; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT VENTRICLE FAILURE; HEART VALVE BIOPROSTHESIS; HEART VALVE PROSTHESIS; HEART VALVE SURGERY; HUMAN; HYPERCOAGULABILITY; INTRACARDIAC THROMBOSIS; MITRAL VALVE DISEASE; MITRAL VALVE PROSTHESIS; MITRAL VALVE REPLACEMENT; MORBIDITY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREGNANCY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SUDDEN DEATH; SURGICAL MORTALITY; THROMBOEMBOLISM; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT INDICATION; VALVULAR HEART DISEASE;

ANTIBIOTIC PROPHYLAXIS; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTENSION, PULMONARY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; VENTRICULAR DYSFUNCTION;

EID: 3042590248     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Lindblom D, Lindblom U, Qvist J, et al. Long-term relative survival rates after heart valve replacement. J Am Coll Cardiol 1990;15:566-73. ▶ A large study of survival rates in consecutive patients after heart valve replacement. Through adjustments in background mortality relative survival rates are presented and thereby identify impartant variables affecting the survival in different valve lesions.
2. Groves P. Surgery of valve disease: late results and late complications. Heart 2001;86:715-21.
3. Enriquez-Sorano M. Timing of mitral valve surgery. Heart 2002;87:79-85.
4. Bloomfield P. Choice of heart valve prosthesis. Heart 2002;87:583-9.
5. Bonow RO, Carabello B, de Leon ACJ, et al. ACC/AHA guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease). Circulation 1998;98:1949-84. ▶ A comprehensive review of all aspects of the management of patients with valvar heart disease including valve replacement surgery.
6. Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients in the United States with prosthetic heart valves. Should ACC/AHA practice guidelines on valve selection be modified? Circulation 2002;105:1336-41.
7. Massel D, Little SH. Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis. J Am Coll Cardiol 2001;37:569-78. ▶ A meta-analysis of the use of warfarin and aspirin in patients with prosthetic heart valves. It is concluded that combining low dose aspirin with warfarin decreases the risk of systemic embolism or death in patients with prosthetic heart valves.
8. Cannegieter S, Rosendaal F, Wintzen A, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11-17.
9. Gohlke-Barwolf C. Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery. Heart 2000;86:715-21.
10. Oezkan M, Kaymaz C, Kirma C, et al. Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using serial transesophageal echocardiography. J Am Coll Cardiol 2000;35:1881-9. ▶ Useful analysis of the results of intravenous thrombolytic treatment in 32 symptomatic patients with prosthetic valve thrombosis. In comparison to other data in the literature, this single centre cohort is relatively large. Initial success using streptokinase was 53% as assessed by transoesophageal echocardiography; it increased to 88% following repeated thrombolytic sessions.
11. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000;160:191-6.
12. Pibarot P, Dumesnil J. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol 2000;36:1131-41. A useful update on the concept of aortic prosthesis-patient mismatch with a review of the present knowledge regarding its impact on haemodynamic status, functional capacity, and patient morbidity and mortality.
13. Mandinov L, Eberli F, Seiler C, et al. Diastolic heart failure. Cardiovasc Res 2000;45:813-25.
14. de Marchi S, Bodenmuller M, Lai D, et al. Pulmonary venous flow velocity patterns in 404 individuals without cardiovascular disease. Heart 2001;85:23-9.
15. Nagueh S, Sun H, Kopelen H, et al. Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol 2001;37:278-85.
16. Porter A, Shapira Y, Wurzel M, et al. Tricuspid regurgitation late after mitral valve replacement: clinical and echocardiographic evaluation. J Heart Valve Dis 1999;8:57-62.
17. Jaffe CC. Echocardiography of the right side of the heart. Cardiology Clinics 1992;10:41-57.
18. Tüller D, Steiner M, Kabok M, et al. Assessment of systolic right ventricular function by Doppler tissue imaging of the tricuspid annulus [abstract]. Eur Heart J 2002;23:426.
19. Krowka MJ. Pulmonary hypertension. Mayo Clin Proc 2000;75:625-30.
20. Piper C, Körfer R, Horstkotte D. Prosthetic valve endocarditis. Heart 2001;85:590-3.
21. Netzer ROM, Altwegg SC, Zollinger E, et al. Infective endocarditis: determinants of long term outcome. Heart 2002;88:61-6. ▶ Retrospective cohort study in 212 patients with infective endocarditis followed far an average of 7.4 years. Survival was 50% after 10 years and was predicted by early surgical treatment, young age, lack of congestive heart failure, and the presence of initial symptoms of endocarditis.